Sign in
4

Changes in Ownership

PMV Pharmaceuticals, Inc. Filed Acc 0001415889-24-024624

Options or other derivatives

  • Chief Financial Officer acquired 115,805 shares (grant or award)
  • Chief Financial Officer returned 115,805 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Carulli Michael Chief Financial Officer 2024-08-13 Returned to the company · Employee Stock Option (right to buy) −13,605 0 D
Carulli Michael Chief Financial Officer 2024-08-13 Returned to the company · Employee Stock Option (right to buy) −27,200 0 D
Carulli Michael Chief Financial Officer 2024-08-13 Grant or award · Employee Stock Option (right to buy) +40,805 40,805 D
Carulli Michael Chief Financial Officer 2024-08-13 Returned to the company · Employee Stock Option (right to buy) −75,000 75,000 D
Carulli Michael Chief Financial Officer 2024-08-13 Grant or award · Employee Stock Option (right to buy) +75,000 75,000 D
Loading xslF345X05/form4-10032024_081040.xml…